<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">IMR</journal-id>
<journal-id journal-id-type="hwp">spimr</journal-id>
<journal-title>Journal of International Medical Research</journal-title>
<issn pub-type="ppub">0300-0605</issn>
<issn pub-type="epub">1473-2300</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0300060513477306</article-id>
<article-id pub-id-type="publisher-id">10.1177_0300060513477306</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Case Reports</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Autosomal-dominant Meesmann epithelial corneal dystrophy without an exon mutation in the keratin-3 or keratin-12 gene in a Chinese family</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Cao</surname><given-names>Wei</given-names></name>
<xref ref-type="aff" rid="aff1-0300060513477306">1</xref>
<xref ref-type="corresp" rid="corresp1-0300060513477306"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Yan</surname><given-names>Ming</given-names></name>
<xref ref-type="aff" rid="aff2-0300060513477306">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Hao</surname><given-names>QianYun</given-names></name>
<xref ref-type="aff" rid="aff2-0300060513477306">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Wang</surname><given-names>ShuLin</given-names></name>
<xref ref-type="aff" rid="aff1-0300060513477306">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Wu</surname><given-names>LiHua</given-names></name>
<xref ref-type="aff" rid="aff1-0300060513477306">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Liu</surname><given-names>Qing</given-names></name>
<xref ref-type="aff" rid="aff1-0300060513477306">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Li</surname><given-names>MingYan</given-names></name>
<xref ref-type="aff" rid="aff1-0300060513477306">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Biddle</surname><given-names>Fred G</given-names></name>
<xref ref-type="aff" rid="aff3-0300060513477306">3</xref>
<xref ref-type="aff" rid="aff4-0300060513477306">4</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Wu</surname><given-names>Wei</given-names></name>
<xref ref-type="aff" rid="aff1-0300060513477306">1</xref>
<xref ref-type="aff" rid="aff5-0300060513477306">5</xref>
</contrib>
</contrib-group>
<aff id="aff1-0300060513477306"><label>1</label>Clinical Research Centre, People's Hospital of Zhengzhou, Zhengzhou, Henan, China</aff>
<aff id="aff2-0300060513477306"><label>2</label>Medical School, Zhengzhou University, Zhengzhou, Henan, China</aff>
<aff id="aff3-0300060513477306"><label>3</label>Department of Medical Genetics, University of Calgary, Calgary, Alberta, Canada</aff>
<aff id="aff4-0300060513477306"><label>4</label>Department of Biological Sciences, University of Calgary, Calgary, Alberta, Canada</aff>
<aff id="aff5-0300060513477306"><label>5</label>Department of Pathology and Experimental Medicine, University of Calgary, Calgary, Alberta, Canada</aff>
<author-notes>
<corresp id="corresp1-0300060513477306">Dr Wei Cao, Clinical Research Centre, People's Hospital of Zhengzhou, 33 Yellow River Road, Zhengzhou, Henan 45003, China. Email: <email>caoweiyu@hotmail.com</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>4</month>
<year>2013</year>
</pub-date>
<volume>41</volume>
<issue>2</issue>
<fpage>511</fpage>
<lpage>518</lpage>
<permissions>
<copyright-statement>© The Author(s)2013 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>Meesmann epithelial corneal dystrophy (MECD) is a dominantly inherited disorder, characterized by fragility of the anterior corneal epithelium and formation of intraepithelial microcysts. It has been described in a number of different ancestral groups. To date, all reported cases of MECD have been associated with either a single mutation in one exon of the keratin-3 gene (<italic>KRT3</italic>) or a single mutation in one of two exons of the keratin-12 gene (<italic>KRT12</italic>). Each mutation leads to a predicted amino acid change in the respective keratin-3 or keratin-12 proteins that combine to form the corneal-specific heterodimeric intermediate filament protein. This case report describes a four-generation Chinese kindred with typical autosomal-dominant MECD. Exon sequencing of <italic>KRT3</italic> and <italic>KRT12</italic> in six affected and eight unaffected individuals (including two spouses) did not detect any mutations or nucleotide sequence variants. This kindred demonstrates that single mis-sense mutations may be sufficient but are not required in all individuals with the MECD phenotype. It provides a unique opportunity to investigate further genomic and functional heterogeneity in MECD.</p>
</abstract>
<kwd-group>
<kwd>Meesmann epithelial corneal dystrophy</kwd>
<kwd><italic>KRT3</italic></kwd>
<kwd><italic>KRT12</italic></kwd>
<kwd>autosomal dominant</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-0300060513477306" sec-type="intro"><title>Introduction</title>
<p>Meesmann epithelial corneal dystrophy (MECD) (OMIM 122 100) is a dominantly inherited disorder of the corneal epithelium, characterized by intraepithelial microcysts of uniform size and shape. It was first reported in three families in northern Germany by Meesmann and Wilke<sup><xref ref-type="bibr" rid="bibr1-0300060513477306">1</xref></sup> in 1939 and was later described in Irish,<sup><xref ref-type="bibr" rid="bibr2-0300060513477306">2</xref></sup> Polish,<sup><xref ref-type="bibr" rid="bibr3-0300060513477306">3</xref></sup> Swiss,<sup><xref ref-type="bibr" rid="bibr4-0300060513477306">4</xref></sup> British,<sup><xref ref-type="bibr" rid="bibr5-0300060513477306">5</xref></sup> American,<sup><xref ref-type="bibr" rid="bibr6-0300060513477306">6</xref><xref ref-type="bibr" rid="bibr7-0300060513477306"/><xref ref-type="bibr" rid="bibr8-0300060513477306"/>–<xref ref-type="bibr" rid="bibr9-0300060513477306">9</xref></sup> Japanese,<sup><xref ref-type="bibr" rid="bibr10-0300060513477306">10</xref></sup> Taiwanese<sup><xref ref-type="bibr" rid="bibr11-0300060513477306">11</xref></sup> and Chinese<sup><xref ref-type="bibr" rid="bibr12-0300060513477306">12</xref></sup> families. MECD is a rare disease and registries of affected cases have not been established, therefore the prevalence and expected incidence of new cases are unknown. The clinical presentation of MECD is variable, ranging from mild to recurrent epithelial erosions, leading to lacrimation, photophobia and deterioration in visual acuity. Slit-lamp examination is considered to be the standard method for diagnosis, showing the typical corneal changes of surface irregularities and epithelial cysts, concentrated most commonly in the interpalpebral zone. Currently there is no specific therapy for MECD; treatment involves palliative relief and prevention of deterioration in visual acuity.</p>
<p>Genetic studies have associated MECD with specific coding variations in the keratin-3 gene (<italic>KRT3</italic>) or the keratin-12 gene (<italic>KRT12</italic>). A protein heterodimer, composed of keratin-3 (a type II keratin) and keratin-12 (a type I keratin), is expressed specifically in the corneal epithelium and is important for keratocyte stability.<sup><xref ref-type="bibr" rid="bibr13-0300060513477306">13</xref>,<xref ref-type="bibr" rid="bibr14-0300060513477306">14</xref></sup> Patterns of kinship-specific mutations in <italic>KRT3</italic> or <italic>KRT12</italic> have been demonstrated in patients with MECD (<xref ref-type="table" rid="table1-0300060513477306">Table 1</xref>). Substitution mutations have only been reported in exon 7 of <italic>KRT3</italic>,<sup><xref ref-type="bibr" rid="bibr2-0300060513477306">2</xref>,<xref ref-type="bibr" rid="bibr3-0300060513477306">3</xref>,<xref ref-type="bibr" rid="bibr11-0300060513477306">11</xref></sup> affecting the helix-termination domain of the keratin-3 protein, but mutational ‘hotspots’ appear in both exon 1<sup><xref ref-type="bibr" rid="bibr1-0300060513477306">1</xref>,<xref ref-type="bibr" rid="bibr2-0300060513477306">2</xref>,<xref ref-type="bibr" rid="bibr5-0300060513477306">5</xref>,<xref ref-type="bibr" rid="bibr7-0300060513477306">7</xref><xref ref-type="bibr" rid="bibr8-0300060513477306"/><xref ref-type="bibr" rid="bibr9-0300060513477306"/>–<xref ref-type="bibr" rid="bibr10-0300060513477306">10</xref>,<xref ref-type="bibr" rid="bibr12-0300060513477306">12</xref>,<xref ref-type="bibr" rid="bibr14-0300060513477306">14</xref><xref ref-type="bibr" rid="bibr15-0300060513477306"/><xref ref-type="bibr" rid="bibr16-0300060513477306"/><xref ref-type="bibr" rid="bibr17-0300060513477306"/><xref ref-type="bibr" rid="bibr18-0300060513477306"/>–<xref ref-type="bibr" rid="bibr19-0300060513477306">19</xref></sup> and exon 6<sup><xref ref-type="bibr" rid="bibr4-0300060513477306">4</xref>,<xref ref-type="bibr" rid="bibr6-0300060513477306">6</xref>,<xref ref-type="bibr" rid="bibr7-0300060513477306">7</xref>,<xref ref-type="bibr" rid="bibr10-0300060513477306">10</xref>,<xref ref-type="bibr" rid="bibr11-0300060513477306">11</xref>,<xref ref-type="bibr" rid="bibr20-0300060513477306">20</xref></sup> of <italic>KRT12</italic>, affecting the helix-initiation and helix-termination domains, respectively, of the keratin-12 protein; in addition, an insertion mutation has been described in the helix-termination domain of the keratin-12 protein.<sup><xref ref-type="bibr" rid="bibr7-0300060513477306">7</xref></sup> The only heritable mutations in MECD are mis-sense mutations that give rise to amino acid substitutions, in what are relatively specific domains of the keratin-3 and keratin-12 proteins.
<table-wrap id="table1-0300060513477306" position="float"><label>Table 1.</label><caption><p>Meesmann epithelial corneal dystrophy (MECD) kindreds reported in the literatur.</p></caption>
<graphic alternate-form-of="table1-0300060513477306" xlink:href="10.1177_0300060513477306-table1.tif"/>
<table frame="hsides"><thead align="left">
<tr><th rowspan="2">Reference</th>
<th colspan="2">Sex of patients with MECD</th>
<th>Proband ancestry</th>
<th colspan="4">Reported <italic>KRT3</italic>/<italic>KRT12</italic> mutation</th>
</tr>
<tr><th>Male, <italic>n</italic></th>
<th>Female, <italic>n</italic></th>
<th>Gene</th>
<th>Exon</th>
<th>Nucleotide</th>
<th>Codon</th>
</tr></thead>
<tbody align="left">
<tr>
<td>Meesmann and Wilke<sup><xref ref-type="bibr" rid="bibr1-0300060513477306">1</xref></sup></td>
<td>9</td>
<td>17</td>
<td>German</td>
<td><italic>KRT12</italic></td>
<td>1</td>
<td>428G &gt;C</td>
<td>R135T</td>
</tr>
<tr>
<td>Ehlers et al.<sup><xref ref-type="bibr" rid="bibr14-0300060513477306">14</xref></sup></td>
<td>0</td>
<td>8</td>
<td><italic>KRT12</italic></td>
<td>1</td>
<td>428G &gt;C</td>
<td>R135T</td>
</tr>
<tr>
<td>Corden et al.<sup><xref ref-type="bibr" rid="bibr15-0300060513477306">15</xref></sup></td>
<td>7</td>
<td>5</td>
<td>German</td>
<td><italic>KRT12</italic></td>
<td>1</td>
<td>428G &gt;C</td>
<td>R135T</td>
</tr>
<tr>
<td>Corden et al.<sup><xref ref-type="bibr" rid="bibr16-0300060513477306">16</xref></sup></td>
<td>4</td>
<td>3</td>
<td>German</td>
<td><italic>KRT12</italic></td>
<td>1</td>
<td>413A &gt;C</td>
<td>Q130P</td>
</tr>
<tr>
<td>Irvine et al.<sup><xref ref-type="bibr" rid="bibr17-0300060513477306">17</xref></sup></td>
<td colspan="2">Unknown</td>
<td>German</td>
<td><italic>KRT12</italic></td>
<td>1</td>
<td>423T &gt;G</td>
<td>N133K</td>
</tr>
<tr>
<td>Clausen et al.<sup><xref ref-type="bibr" rid="bibr18-0300060513477306">18</xref></sup></td>
<td>2</td>
<td>1</td>
<td>German</td>
<td><italic>KRT12</italic></td>
<td>1</td>
<td>409G &gt;A</td>
<td>M129V</td>
</tr>
<tr>
<td>Irvine et al.<sup><xref ref-type="bibr" rid="bibr2-0300060513477306">2</xref></sup></td>
<td>5</td>
<td>3</td>
<td>Irish</td>
<td><italic>KRT3</italic></td>
<td>7</td>
<td>1525G &gt;A</td>
<td>E509K</td>
</tr>
<tr>
<td><italic>KRT12</italic></td>
<td>1</td>
<td>451G &gt;C</td>
<td>V143L</td>
</tr>
<tr>
<td>Szaflik et al.<sup><xref ref-type="bibr" rid="bibr3-0300060513477306">3</xref></sup></td>
<td>2</td>
<td>2</td>
<td>Polish</td>
<td><italic>KRT3</italic></td>
<td>7</td>
<td>1493A &gt;T</td>
<td>E498V</td>
</tr>
<tr>
<td>Nichini et al.<sup><xref ref-type="bibr" rid="bibr4-0300060513477306">4</xref></sup></td>
<td>4</td>
<td>4</td>
<td>Swiss</td>
<td><italic>KRT12</italic></td>
<td>6</td>
<td>1301T &gt;G</td>
<td>I426S</td>
</tr>
<tr>
<td>Liao et al.<sup><xref ref-type="bibr" rid="bibr5-0300060513477306">5</xref></sup></td>
<td>1</td>
<td>4</td>
<td>British</td>
<td><italic>KRT12</italic></td>
<td>1</td>
<td>395T &gt;C</td>
<td>L132P</td>
</tr>
<tr>
<td>Corden et al.<sup><xref ref-type="bibr" rid="bibr15-0300060513477306">15</xref></sup></td>
<td>4</td>
<td>4</td>
<td>American</td>
<td><italic>KRT12</italic></td>
<td>1</td>
<td>410T &gt;C</td>
<td>M129T</td>
</tr>
<tr>
<td>Yoon et al.<sup><xref ref-type="bibr" rid="bibr7-0300060513477306">7</xref></sup></td>
<td>0</td>
<td>1</td>
<td>American</td>
<td><italic>KRT12</italic></td>
<td>1</td>
<td>429A &gt;C</td>
<td>R135S</td>
</tr>
<tr>
<td>0</td>
<td>3</td>
<td>American</td>
<td><italic>KRT12</italic></td>
<td>6</td>
<td>1222ins27</td>
<td>400ins- 9ISNLEAQLL</td>
</tr>
<tr>
<td>Coleman et al.<sup><xref ref-type="bibr" rid="bibr6-0300060513477306">6</xref></sup></td>
<td>1</td>
<td>0</td>
<td>American</td>
<td><italic>KRT12</italic></td>
<td>6</td>
<td>1300A &gt;G</td>
<td>I426V</td>
</tr>
<tr>
<td>Sullivan et al.<sup><xref ref-type="bibr" rid="bibr20-0300060513477306">20</xref></sup></td>
<td>9</td>
<td>8</td>
<td>American</td>
<td><italic>KRT12</italic></td>
<td>6</td>
<td>1287G &gt;C</td>
<td>A430P</td>
</tr>
<tr>
<td>Stocker and Holt,<sup><xref ref-type="bibr" rid="bibr8-0300060513477306">8</xref></sup> Klintworth<sup><xref ref-type="bibr" rid="bibr9-0300060513477306">9</xref></sup></td>
<td>11</td>
<td>9</td>
<td>American</td>
<td><italic>KRT12</italic></td>
<td>1</td>
<td>Not listed</td>
<td>R19I</td>
</tr>
<tr>
<td>Nishida et al.<sup><xref ref-type="bibr" rid="bibr10-0300060513477306">10</xref></sup></td>
<td>5</td>
<td>1</td>
<td>Japanese</td>
<td><italic>KRT12</italic></td>
<td>1</td>
<td>427A &gt;G</td>
<td>R135G</td>
</tr>
<tr>
<td>1</td>
<td>2</td>
<td>Japanese</td>
<td><italic>KRT12</italic></td>
<td>1</td>
<td>428G &gt;T</td>
<td>R135I</td>
</tr>
<tr>
<td>1</td>
<td>1</td>
<td>Japanese</td>
<td><italic>KRT12</italic></td>
<td>6</td>
<td>4064T &gt;G</td>
<td>Y429D</td>
</tr>
<tr>
<td>0</td>
<td>1</td>
<td>Japanese</td>
<td><italic>KRT12</italic></td>
<td>1</td>
<td>443T &gt;G</td>
<td>L140R</td>
</tr>
<tr>
<td>Takahashi et al.<sup><xref ref-type="bibr" rid="bibr19-0300060513477306">19</xref></sup></td>
<td>1</td>
<td>2</td>
<td>Japanese</td>
<td><italic>KRT12</italic></td>
<td>1</td>
<td>433G &gt;C</td>
<td>A137P</td>
</tr>
<tr>
<td>Chen et al.<sup><xref ref-type="bibr" rid="bibr11-0300060513477306">11</xref></sup></td>
<td>1</td>
<td>1</td>
<td>Taiwanese</td>
<td><italic>KRT3</italic></td>
<td>7</td>
<td>1508G &gt;C</td>
<td>R503P</td>
</tr>
<tr>
<td>2</td>
<td>2</td>
<td>Taiwanese</td>
<td><italic>KRT12</italic></td>
<td>6</td>
<td>1286A &gt;G</td>
<td>Y429C</td>
</tr>
<tr>
<td>Wang et al.<sup><xref ref-type="bibr" rid="bibr12-0300060513477306">12</xref></sup></td>
<td>7</td>
<td>5</td>
<td>Chinese</td>
<td><italic>KRT12</italic></td>
<td>1</td>
<td>419T &gt;A</td>
<td>L132H</td>
</tr>
<tr>
<td>Current case report</td>
<td>8</td>
<td>0</td>
<td>Chinese</td>
<td colspan="4">No mutation found</td>
</tr>
<tr>
<td>Total</td>
<td>85</td>
<td>87</td>
</tr>
</tbody>
</table>
</table-wrap></p>
<p>Direct sequencing of the coding exons of <italic>KRT3</italic> and <italic>KRT12</italic> appears to be an effective strategy to confirm the genetic cause of dominant MECD. Sequencing both <italic>KRT3</italic> and <italic>KRT12</italic> exons is critical, since sequence variants do not always co-segregate with MECD within a kinship. For example, a <italic>KRT12</italic> exon mutation was detected in one family but did not co-segregate with the MECD phenotype; instead an exon 7 mutation in <italic>KRT3</italic> co-segregated with the MECD trait and was considered to be the causative mutation.<sup><xref ref-type="bibr" rid="bibr3-0300060513477306">3</xref></sup> There is therefore the potential for genomic heterogeneity to be uncovered in MECD, but to date only a few, rare, dominant-negative mutations appear to co-segregate with the MECD phenotype.</p>
<p>The present case report describes a four-generation Chinese kindred with MECD but no detectable exon mutation of either <italic>KRT3</italic> or <italic>KRT12</italic>, suggesting that this rare dominant-negative genetic disorder may have undefined genetic variants in a noncoding region, or in regulatory elements, that will require further genomic analysis.</p>
</sec>
<sec id="sec2-0300060513477306" sec-type="cases"><title>Case report</title>
<p>A four-generation Chinese family including six living individuals with MECD was studied (<xref ref-type="fig" rid="fig1-0300060513477306">Figure 1</xref>). The proband was a 20-year-old male (IV-4) who presented to the People's Hospital of Zhengzhou, Zhengzhou, Henan, China, in May 2011 with blurred vision, irritation, tearing and frequent photophobia. Visual acuity was normal (1.2 in both eyes). Multiple small cysts were seen on slit-lamp examination. His father (III-4) had a similar eye problem, which drew the family to clinical attention. Subsequently, the extended four-generation family was assessed. A complete ophthalmological assessment, including slit-lamp examination, was performed in 14 family members (II2, II3, III1, III4, III5, III6, III7, III11, III12, IV2, IV3, IV4, IV5 and IV6).
<fig id="fig1-0300060513477306" position="float"><label>Figure 1.</label><caption><p>Pedigree of a Chinese family with Meesmann epithelial corneal dystrophy, showing autosomal dominant inheritance. Affected individuals are represented by a solid symbol; the proband is IV-4.</p></caption><graphic xlink:href="10.1177_0300060513477306-fig1.tif"/>
</fig></p>
<p>Eight individuals were found to be affected by MECD (<xref ref-type="fig" rid="fig1-0300060513477306">Figure 1</xref>). All were males and ranged between 20 (IV-4) and 80 (II-2) years old; affected individuals I-1 and III-3 were no longer alive but were identified from family description. Vision was very poor in both eyes for individuals II-2, II-3, III-4, III-6 and III-12. In addition, two individuals who did not have MECD were diagnosed with pathological myopia (III-1 and IV-2). Slit-lamp examination showed multiple fine vesicles (microcysts) within the corneal epithelia in both eyes (<xref ref-type="fig" rid="fig2-0300060513477306">Figure 2</xref>) in all affected living individuals, leading to a primary diagnosis of MECD.
<fig id="fig2-0300060513477306" position="float"><label>Figure 2.</label><caption><p>Slit-lamp photography of the left eye of patient III-12 with Meesmann epithelial corneal dystrophy. The corneal epithelium has an irregular surface with multiple microcysts, with erupted cysts forming opaque spots. The black arrow indicates a representative cyst within the corneal epithelium.</p></caption><graphic xlink:href="10.1177_0300060513477306-fig2.tif"/>
</fig></p>
<p>After obtaining written informed consent according to clinical research guidelines approved by the Institutional Review Board of the People's Hospital of Zhengzhou, Zhengzhou, Henan, China, 3-ml peripheral blood samples were obtained in tubes containing ethylenediamine tetra-acetic acid from all six affected living patients (II-2, II-3, III-4, III-6, III-12 and IV-4), six unaffected individuals (III-1, III-11, IV-2, IV-3, IV-5 and IV-6) and two nongenetic relatives (III-5 and III-7), for the isolation of genomic DNA and assessment of exon mutations in <italic>KRT3</italic> and <italic>KRT12.</italic>The tube was inverted to mix the sample. Blood samples were stored at 4°C and analysed within 8 h of collection. To separate the peripheral blood leucocytes, 1 ml blood of blood was transferred to a 1.5-ml Eppendorf tube. The sample was then centrifuged for 10 min at 1200 r.p.m., at room temperature, (Model 5430, Eppendorf AG, Hamburg, Germany) to pellet red blood cells from plasma. The thin layer of buffy coat was carefully aspirated from between the pelleted red blood cells and plasma, and was transferred to a fresh tube for DNA isolation.</p>
<p>Genomic DNA was isolated from peripheral blood leucocytes by standard procedures using a blood DNA kit (Qiagen, Valencia, CA, USA). Coding regions of <italic>KRT3</italic> (NM_057088) and <italic>KRT12</italic> (NM_000223) were screened for mutations by direct sequencing, using DNA amplified with the primers shown in <xref ref-type="table" rid="table2-0300060513477306">Table 2</xref>. Polymerase chain reaction (PCR) was performed at 94°C for 5 min followed by 35 cycles at 94°C for 30 s, 57°C for 30 s, 72°C for 30 s and 72°C for 5 min. PCR-amplified products were examined on 1% agarose gels, then sequenced using an ABI Prism® 377 DNA sequencer (Applied Biosystems, Foster City, CA, USA) and BigDye® termination cycle-sequencing kit version 3.1 (Applied Biosystems).
<table-wrap id="table2-0300060513477306" position="float"><label>Table 2.</label><caption><p>Primers used in polymerase chain reaction amplification for direct sequencing of <italic>KRT3</italic> and <italic>KRT12</italic> exon.</p></caption>
<graphic alternate-form-of="table2-0300060513477306" xlink:href="10.1177_0300060513477306-table2.tif"/>
<table frame="hsides"><thead align="left">
<tr><th colspan="2">Target</th>
<th>Forward primer sequence</th>
<th>Reverse primer sequence</th>
<th>Product size, bp</th>
<th><italic>T</italic><sub>m</sub>, °C</th>
</tr>
<tr><th>Gene</th>
<th>Exon</th>
</tr></thead>
<tbody align="left">
<tr>
<td><italic>KRT3</italic></td>
<td>1-1</td>
<td>5′-TGGAACAAACTTATTGCCTTG-3′</td>
<td>5′-CACCAGGACTGCCCAAGC-3′</td>
<td>680</td>
<td>57.8</td>
</tr>
<tr>
<td>1-2</td>
<td><sc>5′-</sc>CAGTCGCAGCCTCTACAACC<sc>-3′</sc></td>
<td><sc>5′-</sc>ACAAACTCCTCAACCCTGGA<sc>-3′</sc></td>
<td>647</td>
<td>59.6</td>
</tr>
<tr>
<td>2</td>
<td><sc>5′-</sc>CGCTGCAAGTGTAGTGTCCT<sc>-3′</sc></td>
<td><sc>5′-</sc>GTGAGGGGGAACTGAATGAA<sc>-3′</sc></td>
<td>580</td>
<td>59.1</td>
</tr>
<tr>
<td>3</td>
<td><sc>5′-</sc>CCCCCAACTAACAGGGAGAT<sc>-3′</sc></td>
<td><sc>5′-</sc>ATAGGCACTGTCCACATCCTG<sc>-3′</sc></td>
<td>595</td>
<td>60.0</td>
</tr>
<tr>
<td>4</td>
<td><sc>5′-</sc>CCGTTCAAGTGGAGACTGGT<sc>-3′</sc></td>
<td><sc>5′-</sc>GTATCAGCCACACCCTGTCC<sc>-3′</sc></td>
<td>422</td>
<td>60.1</td>
</tr>
<tr>
<td>5</td>
<td><sc>5′-</sc>GAATGAGCCTGGAGATGAGG<sc>-3′</sc></td>
<td><sc>5′-</sc>TTTCTGCAACTGAACCACCA<sc>-3′</sc></td>
<td>531</td>
<td>59.8</td>
</tr>
<tr>
<td>6</td>
<td><sc>5′-</sc>CCCTGCTGAAACACAATGC<sc>-3′</sc></td>
<td><sc>5′-</sc>CTCCCCTAGTGCCTCCATCT<sc>-3′</sc></td>
<td>426</td>
<td>60.3</td>
</tr>
<tr>
<td>7</td>
<td><sc>5′-</sc>CACAGGGCAGTATCTCCACA<sc>-3′</sc></td>
<td><sc>5′-</sc>GCAAATGCTTCACCACAAGG<sc>-3′</sc></td>
<td>499</td>
<td>59.7</td>
</tr>
<tr>
<td>8</td>
<td><sc>5′-</sc>CTCCTTGCTACAGCCCAAAG<sc>-3′</sc></td>
<td><sc>5′-</sc>AGCCAATCACTTCCCTCTCC<sc>-3′</sc></td>
<td>327</td>
<td>60.0</td>
</tr>
<tr>
<td>9-1</td>
<td><sc>5′-</sc>GCTCGTGGTGAACATCCTG<sc>-3′</sc></td>
<td><sc>5′-</sc>AATTCTCGTGACTGGGCTTG<sc>-3′</sc></td>
<td>627</td>
<td>60.2</td>
</tr>
<tr>
<td>9-2</td>
<td><sc>5′-</sc>GCTTTGGCTCCATCTCTGG<sc>-3′</sc></td>
<td><sc>5′-</sc>AGACGAACTGCCTTTGTTTCA<sc>-3′</sc></td>
<td>639</td>
<td>59.9</td>
</tr>
<tr>
<td><italic>KRT12</italic></td>
<td>1-1</td>
<td><sc>5′-</sc>CCACCCAGCTTTCTTTTTCA<sc>-3′</sc></td>
<td><sc>5′-</sc>CGCACCTTATCCAGGTAGGA<sc>-3′</sc></td>
<td>683</td>
<td>60.1</td>
</tr>
<tr>
<td>1-2</td>
<td><sc>5′-</sc>GTTATGGGGGAAGTGCCTTT<sc>-3′</sc></td>
<td><sc>5′-</sc>TGAAACAACCTGGGATGAGA<sc>-3′</sc></td>
<td>588</td>
<td>59.1</td>
</tr>
<tr>
<td>2</td>
<td><sc>5′-</sc>CCCAGGTTGTTTCACTCCAC<sc>-3′</sc></td>
<td><sc>5′-</sc>TTGAGGTTTAGGACACTGGTAGG<sc>-3′</sc></td>
<td>632</td>
<td>59.6</td>
</tr>
<tr>
<td>3</td>
<td><sc>5′-</sc>CAACAGCAAAAACTGCATCA<sc>-3′</sc></td>
<td><sc>5′-</sc>CCTTAGCAGGAACCACCATC<sc>-3′</sc></td>
<td>520</td>
<td>58.5</td>
</tr>
<tr>
<td>4 and 5</td>
<td><sc>5′-</sc>CCAACTTACCCATTAGGCACA<sc>-3′</sc></td>
<td><sc>5′-</sc>TCCAGGGATTTCTTCTGCAC<sc>-3′</sc></td>
<td>848</td>
<td>59.9</td>
</tr>
<tr>
<td>6</td>
<td><sc>5′-</sc>GCGCAAACAGACGTAGCAT<sc>-3′</sc></td>
<td><sc>5′-</sc>TCCCAGGCATATCTTTACTAGACTT<sc>-3′</sc></td>
<td>485</td>
<td>58.8</td>
</tr>
<tr>
<td>7</td>
<td><sc>5′-</sc>GCCACCTGAACCACCTACTC<sc>-3′</sc></td>
<td><sc>5′-</sc>AGATGGGGTCTCGCTATTTG<sc>-3′</sc></td>
<td>544</td>
<td>59.2</td>
</tr>
<tr>
<td>8-1</td>
<td><sc>5′-</sc>GGCAAAGCAGAAGGGAAAA<sc>-3′</sc></td>
<td><sc>5′-</sc>TGTTGGAATCAAGGCATACA<sc>-3′</sc></td>
<td>776</td>
<td>57.5</td>
</tr>
<tr>
<td>8-2</td>
<td><sc>5′-</sc>TGGTGAATGGTGAGGTGGT<sc>-3′</sc></td>
<td><sc>5′-</sc>CCTGACATCTTCATCCCAGTT<sc>-3′</sc></td>
<td>676</td>
<td>59.0</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0300060513477306"><p><italic>T</italic><sub>m</sub>, melting temperature.</p></fn></table-wrap-foot>
</table-wrap></p>
<p>No sequence variants were identified: all individuals were homozygous for the exons of <italic>KRT3</italic> and <italic>KRT12</italic>.</p>
</sec>
<sec id="sec3-0300060513477306" sec-type="discussion"><title>Discussion</title>
<p>This large Chinese kindred is the first published report of an autosomal-dominant MECD trait that is not associated with an exon mutation in either <italic>KRT3</italic> or <italic>KRT12</italic>. MECD is an autosomal-dominant genetic disorder affecting the corneal epithelium that was first identified in Germany in 1939<sup><xref ref-type="bibr" rid="bibr1-0300060513477306">1</xref></sup> and subsequently has been reported worldwide (<xref ref-type="table" rid="table1-0300060513477306">Table 1</xref>). The kindred presented here focuses attention on several genetic properties of MECD.</p>
<p>First, in autosomal-dominant MECD, equal numbers of affected males and females would be expected, as shown in <xref ref-type="table" rid="table1-0300060513477306">Table 1</xref>. In the kindred presented here, there were eight affected males and no affected females. However, the absence of affected females in this family is not biologically significant, as the sex ratio and the number of affected children produced by the six affected MECD males who did have children did not show a statistical difference from expected values (<italic>P</italic> = 0.05, using a two-tailed Fisher exact probability test).</p>
<p>Secondly, all well-documented and reported MECD cases have an identified dominant-negative exon mutation in one of the two keratin genes, <italic>KRT3</italic> or <italic>KRT12.</italic> Mutations in <italic>KRT3</italic> have been identified in three MECD ancestries; mutations in <italic>KRT12</italic> have been identified in 22 ancestries (<xref ref-type="table" rid="table1-0300060513477306">Table 1</xref>). Although MECD is rare, the same mutation occurs in all the affected individuals in each reported kindred. Therefore, sequencing the coding exons of <italic>KRT3</italic> and <italic>KRT12</italic> appeared to be an appropriate genetic test to confirm the clinical diagnosis. However, it is now conceivable that there may be an undefined genomic variation in MECD that is not a <italic>KRT3</italic> or <italic>KRT12</italic> exon mutation, but is instead a mutation in the noncoding intron or regulatory elements of these genes.</p>
<p>Thirdly, despite the presence of a kinship-specific dominant-negative mutation in various reported MECD families, clinical phenotype can be variable within the kindred.<sup><xref ref-type="bibr" rid="bibr14-0300060513477306">14</xref></sup> This further suggests that mechanisms unrelated to <italic>KRT3</italic> or <italic>KRT12</italic> mutations may contribute to the phenotypic expression of the MECD trait.<sup><xref ref-type="bibr" rid="bibr3-0300060513477306">3</xref>,<xref ref-type="bibr" rid="bibr14-0300060513477306">14</xref></sup></p>
<p>Further investigation of the kindred presented here should include sequencing the noncoding regions of <italic>KRT3</italic> and <italic>KRT12</italic> in affected individuals and genome-wide association analysis.</p>
</sec>
</body>
<back><ack>
<title>Acknowledgements</title>
<p>We thank the members of the Chinese family presented for their enthusiastic participation in this research and their consent for us to publish the results.</p></ack>
<sec id="sec4-0300060513477306"><title>Declaration of conflicting interest</title>
<p>The authors declare that there are no conflicts of interest.</p>
</sec>
<sec id="sec5-0300060513477306"><title>Funding</title>
<p>This work was supported by the National Natural Science Foundation of China (no. 81171992) and the Zhengzhou Science and Technology Programme (121PPTGG494-8).</p>
</sec>
<ref-list>
<title>References</title>
<ref id="bibr1-0300060513477306"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meesmann</surname><given-names>A</given-names></name><name><surname>Wilke</surname><given-names>F</given-names></name></person-group>. <article-title>Klinische und anatomische Untersuchungen über eine bisher unbekannte, dominant vererbte Epithel Dystrophie der Hornhaut</article-title>. <source>Klin Monatsbl Augenheilkd</source> <year>1939</year>; <volume>103</volume>: <fpage>361</fpage>–<lpage>391</lpage>. <comment>in German</comment>.</citation></ref>
<ref id="bibr2-0300060513477306"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Irvine</surname><given-names>AD</given-names></name><name><surname>Corden</surname><given-names>LD</given-names></name><name><surname>Swensson</surname><given-names>O</given-names></name><etal/></person-group>. <article-title>Mutations in cornea-specific keratin <italic>K3</italic> or <italic>K12</italic> genes cause Meesmann's corneal dystrophy</article-title>. <source>Nat Genet</source> <year>1997</year>; <volume>16</volume>: <fpage>184</fpage>–<lpage>187</lpage>.</citation></ref>
<ref id="bibr3-0300060513477306"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Szaflik</surname><given-names>JP</given-names></name><name><surname>Oldak</surname><given-names>M</given-names></name><name><surname>Maksym</surname><given-names>RB</given-names></name><etal/></person-group>. <article-title>Genetics of Meesmann corneal dystrophy: a novel mutation in the keratin 3 gene in an asymptomatic family suggests genotype-phenotype correlation</article-title>. <source>Mol Vis</source> <year>2008</year>; <volume>14</volume>: <fpage>1713</fpage>–<lpage>1718</lpage>.</citation></ref>
<ref id="bibr4-0300060513477306"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nichini</surname><given-names>O</given-names></name><name><surname>Manzi</surname><given-names>V</given-names></name><name><surname>Munier</surname><given-names>FL</given-names></name><etal/></person-group>. <article-title>Meesmann corneal dystrophy (MECD): report of 2 families and a novel mutation in the cornea specific keratin 12 (<italic>KRT12</italic>) gene</article-title>. <source>Ophthalmic Genet</source> <year>2005</year>; <volume>26</volume>: <fpage>169</fpage>–<lpage>173</lpage>.</citation></ref>
<ref id="bibr5-0300060513477306"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>H</given-names></name><name><surname>Irvine</surname><given-names>AD</given-names></name><name><surname>Macewen</surname><given-names>CJ</given-names></name><etal/></person-group>. <article-title>Development of allele-specific therapeutic siRNA in Meesmann epithelial corneal dystrophy</article-title>. <source>PloS One</source> <year>2011</year>; <volume>6</volume>: <fpage>e28582</fpage>–<lpage>e28582</lpage>.</citation></ref>
<ref id="bibr6-0300060513477306"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Coleman</surname><given-names>CM</given-names></name><name><surname>Hannush</surname><given-names>S</given-names></name><name><surname>Covello</surname><given-names>SP</given-names></name><etal/></person-group>. <article-title>A novel mutation in the helix termination motif of keratin K12 in a US family with Meesmann corneal dystrophy</article-title>. <source>Am J Ophthalmol</source> <year>1999</year>; <volume>128</volume>: <fpage>687</fpage>–<lpage>691</lpage>.</citation></ref>
<ref id="bibr7-0300060513477306"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yoon</surname><given-names>MK</given-names></name><name><surname>Warren</surname><given-names>JF</given-names></name><name><surname>Holsclaw</surname><given-names>DS</given-names></name><etal/></person-group>. <article-title>A novel arginine substitution mutation in 1A domain and a novel 27 bp insertion mutation in 2B domain of keratin 12 gene associated with Meesmann's corneal dystrophy</article-title>. <source>Br J Ophthalmol</source> <year>2004</year>; <volume>88</volume>: <fpage>752</fpage>–<lpage>756</lpage>.</citation></ref>
<ref id="bibr8-0300060513477306"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stocker</surname><given-names>FW</given-names></name><name><surname>Holt</surname><given-names>LB</given-names></name></person-group>. <article-title>A rare form of hereditary epithelial dystrophy of the cornea: a genetic, clinical, and pathologic study</article-title>. <source>Trans Am Ophthalmol Soc</source> <year>1954–1955</year>; <volume>52</volume>: <fpage>133</fpage>–<lpage>144</lpage>.</citation></ref>
<ref id="bibr9-0300060513477306"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Klintworth</surname><given-names>GK</given-names></name></person-group>. <article-title>Advances in the molecular genetics of corneal dystrophies</article-title>. <source>Am J Ophthalmol</source> <year>1999</year>; <volume>128</volume>: <fpage>747</fpage>–<lpage>754</lpage>.</citation></ref>
<ref id="bibr10-0300060513477306"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nishida</surname><given-names>K</given-names></name><name><surname>Honma</surname><given-names>Y</given-names></name><name><surname>Dota</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Isolation and chromosomal localization of a cornea-specific human keratin 12 gene and detection of four mutations in Meesmann corneal epithelial dystrophy</article-title>. <source>Am J Hum Genet</source> <year>1997</year>; <volume>61</volume>: <fpage>1268</fpage>–<lpage>1275</lpage>.</citation></ref>
<ref id="bibr11-0300060513477306"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>YT</given-names></name><name><surname>Tseng</surname><given-names>SH</given-names></name><name><surname>Chao</surname><given-names>SC</given-names></name></person-group>. <article-title>Novel mutations in the helix termination motif of keratin 3 and keratin 12 in 2 Taiwanese families with Meesmann corneal dystrophy</article-title>. <source>Cornea</source> <year>2005</year>; <volume>24</volume>: <fpage>928</fpage>–<lpage>932</lpage>.</citation></ref>
<ref id="bibr12-0300060513477306"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>LJ</given-names></name><name><surname>Tian</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>QS</given-names></name><etal/></person-group>. <article-title>Analysis of mutation in <italic>KRT12</italic> gene in a Chinese family with Meesmann's corneal dystrophy</article-title>. <source>Zhonghua Yan Ke Za Zhi</source> <year>2007</year>; <volume>43</volume>: <fpage>885</fpage>–<lpage>889</lpage>. <comment>in Chinese, English abstract</comment>.</citation></ref>
<ref id="bibr13-0300060513477306"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kao</surname><given-names>WW</given-names></name><name><surname>Liu</surname><given-names>CY</given-names></name><name><surname>Converse</surname><given-names>RL</given-names></name><etal/></person-group>. <article-title>Keratin 12-deficient mice have fragile corneal epithelia</article-title>. <source>Invest Ophthalmol Vis Sci</source> <year>1996</year>; <volume>37</volume>: <fpage>2572</fpage>–<lpage>2584</lpage>.</citation></ref>
<ref id="bibr14-0300060513477306"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ehlers</surname><given-names>N</given-names></name><name><surname>Hjortdal</surname><given-names>J</given-names></name><name><surname>Nielsen</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Phenotypic variability in Meesmann's dystrophy: clinical review of the literature and presentation of a family genetically identical to the original family</article-title>. <source>Acta Ophthalmol</source> <year>2008</year>; <volume>86</volume>: <fpage>40</fpage>–<lpage>44</lpage>.</citation></ref>
<ref id="bibr15-0300060513477306"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Corden</surname><given-names>LD</given-names></name><name><surname>Swensson</surname><given-names>O</given-names></name><name><surname>Swensson</surname><given-names>B</given-names></name><etal/></person-group>. <article-title>Molecular genetics of Meesmann's corneal dystrophy: ancestral and novel mutations in keratin 12 (K12) and complete sequence of the human <italic>KRT12</italic> gene</article-title>. <source>Exp Eye Res</source> <year>2000</year>; <volume>70</volume>: <fpage>41</fpage>–<lpage>49</lpage>.</citation></ref>
<ref id="bibr16-0300060513477306"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Corden</surname><given-names>LD</given-names></name><name><surname>Swensson</surname><given-names>O</given-names></name><name><surname>Swensson</surname><given-names>B</given-names></name><etal/></person-group>. <article-title>A novel keratin 12 mutation in a German kindred with Meesmann's corneal dystrophy</article-title>. <source>Br J Ophthalmol</source> <year>2000</year>; <volume>84</volume>: <fpage>527</fpage>–<lpage>530</lpage>.</citation></ref>
<ref id="bibr17-0300060513477306"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Irvine</surname><given-names>AD</given-names></name><name><surname>Coleman</surname><given-names>CM</given-names></name><name><surname>Moore</surname><given-names>JE</given-names></name><etal/></person-group>. <article-title>A novel mutation in <italic>KRT12</italic> associated with Meesmann's epithelial corneal dystrophy</article-title>. <source>Br J Ophthalmol</source> <year>2002</year>; <volume>86</volume>: <fpage>729</fpage>–<lpage>732</lpage>.</citation></ref>
<ref id="bibr18-0300060513477306"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Clausen</surname><given-names>I</given-names></name><name><surname>Duncker</surname><given-names>GI</given-names></name><name><surname>Grünauer-Kloevekorn</surname><given-names>C</given-names></name></person-group>. <article-title>Identification of a novel mutation in the cornea specific keratin 12 gene causing Meesmann's corneal dystrophy in a German family</article-title>. <source>Mol Vis</source> <year>2010</year>; <volume>16</volume>: <fpage>954</fpage>–<lpage>960</lpage>.</citation></ref>
<ref id="bibr19-0300060513477306"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>K</given-names></name><name><surname>Takahashi</surname><given-names>K</given-names></name><name><surname>Murakami</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Heterozygous Ala137Pro mutation in keratin 12 gene found in Japanese with Meesmann's corneal dystrophy</article-title>. <source>Jpn J Ophthalmol</source> <year>2002</year>; <volume>46</volume>: <fpage>673</fpage>–<lpage>674</lpage>.</citation></ref>
<ref id="bibr20-0300060513477306"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname><given-names>LS</given-names></name><name><surname>Baylin</surname><given-names>EB</given-names></name><name><surname>Font</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>A novel mutation of the keratin 12 gene responsible for a severe phenotype of Meesmann's corneal dystrophy</article-title>. <source>Mol Vis</source> <year>2007</year>; <volume>13</volume>: <fpage>975</fpage>–<lpage>980</lpage>.</citation></ref>
</ref-list>
</back>
</article>